IL162118A0 - Pharmaceutical compositions containing an orally active taxane derivative - Google Patents

Pharmaceutical compositions containing an orally active taxane derivative

Info

Publication number: IL162118A0
Authority: IL; Israel
Prior art keywords: pharmaceutical compositions; compositions containing; orally active; taxane derivative; active taxane
Prior art date: 2001-12-20

Application number

IL16211802A

Other languages

English (en)

Original Assignee

Bristol Myers Squibb Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-20

Filing date

2002-12-12

Publication date

2005-11-20

2002-12-12 Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co

2005-11-20 Publication of IL162118A0 publication Critical patent/IL162118A0/xx

Links

239000008194 pharmaceutical composition Substances 0.000 title 1
DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Oil, Petroleum & Natural Gas (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Dermatology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Epoxy Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

IL16211802A 2001-12-20 2002-12-12 Pharmaceutical compositions containing an orally active taxane derivative IL162118A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US34288901P	2001-12-20	2001-12-20
PCT/US2002/040127 WO2003053350A2 (fr)	2001-12-20	2002-12-12	Compositions pharmaceutques de derives de taxane actifs par voie buccale a biodisponibilite amelioree

Publications (1)

Publication Number	Publication Date
IL162118A0 true IL162118A0 (en)	2005-11-20

Family

ID=23343716

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL16211802A IL162118A0 (en)	2001-12-20	2002-12-12	Pharmaceutical compositions containing an orally active taxane derivative

Country Status (24)

Country	Link
US (1)	US20030220391A1 (fr)
EP (1)	EP1465618A2 (fr)
JP (1)	JP2006501134A (fr)
KR (1)	KR20040066921A (fr)
CN (1)	CN1273130C (fr)
AR (1)	AR037951A1 (fr)
AU (1)	AU2002361701A1 (fr)
BR (1)	BR0215184A (fr)
CA (1)	CA2470826A1 (fr)
GE (1)	GEP20063806B (fr)
HR (1)	HRP20040545A2 (fr)
HU (1)	HUP0500843A2 (fr)
IL (1)	IL162118A0 (fr)
IS (1)	IS7306A (fr)
MX (1)	MXPA04005877A (fr)
NO (1)	NO20043101L (fr)
PE (1)	PE20030742A1 (fr)
PL (1)	PL374283A1 (fr)
RS (1)	RS52904A (fr)
RU (1)	RU2004119557A (fr)
TW (1)	TW200302086A (fr)
UY (1)	UY27598A1 (fr)
WO (1)	WO2003053350A2 (fr)
ZA (1)	ZA200404584B (fr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BR0307913A (pt) *	2002-02-25	2005-01-11	Lyfjathroun Hf	Uso de uma composição, composição farmacêutica para administração nasal, e, métodos para eliciar um efeito terapêutico, profilático e/ou diagnóstico em um mamìfero, para obter um inìcio rápido de um efeito terapêutico, profilático e/ou diagnóstico de uma substância ativa em um mamìfero e para melhorar a biodisponibilidade de um efeito terapêutico, profilático e/ou diagnóstico de uma substância ativa em um mamìfero
US6855332B2 (en) *	2002-07-03	2005-02-15	Lyfjathroun Hf.	Absorption promoting agent
KR100533458B1 (ko) *	2002-07-20	2005-12-07	대화제약 주식회사	파클리탁셀의 가용화용 조성물 및 그의 제조 방법
EP1498120A1 (fr) *	2003-07-18	2005-01-19	Aventis Pharma S.A.	Formulation semi-solide pour l'administration orale du taxol
CA2539975C (fr)	2003-09-25	2012-11-20	Tapestry Pharmaceuticals, Inc.	Analogues de 9,10-.alpha.,.alpha.-oh-taxane et procedes de fabrication correspondants
US20060088591A1 (en) *	2004-10-22	2006-04-27	Jinghua Yuan	Tablets from a poorly compressible substance
WO2006058121A1 (fr) *	2004-11-23	2006-06-01	Bristol-Myers Squibb Company	Formes cristallines de 3'-tert-butyl-3'-n-tert-butyloxycarbonyl-4-deacetyl-3'-dephenyl-3'-n-debenzoyl-4-o-methoxycarbonyl-paclitaxel
CN105879114A (zh) *	2005-02-18	2016-08-24	阿布拉西斯生物科学公司	用于整合入医疗装置的疏水性改善的药物
AU2012202903B2 (en) *	2005-02-18	2014-12-11	Abraxis Bioscience, Inc.	Drugs with improved hydrophobicity for incorporation in medical devices
JP5436856B2 (ja)	2005-07-15	2014-03-05	アンジオケムインコーポレーティッド	薬学的複合体における担体としてのアプロチニンポリペプチドの使用
US20070015834A1 (en) *	2005-07-18	2007-01-18	Moshe Flashner-Barak	Formulations of fenofibrate containing PEG/Poloxamer
KR101420445B1 (ko)	2005-08-31	2014-07-16	아브락시스 바이오사이언스, 엘엘씨	수 난용성 제약학적 약제 및 항균제를 포함하는 조성물
WO2007134354A1 (fr) *	2006-05-23	2007-11-29	Ebewe Pharma Ges.M.B.H. Nfg. Kg	Formulation pharmaceutique
US11786504B2 (en)	2006-09-28	2023-10-17	Tapestry Pharmaceuticals, Inc.	Taxane analogs for the treatment of brain cancer
WO2008121476A1 (fr)	2007-03-28	2008-10-09	Tapestry Pharmaceuticals, Inc.	Analogues de taxane biologiquement actifs, et procédés de traitement par administration orale
US11873308B2 (en)	2006-11-06	2024-01-16	Tapestry Pharmaceuticals, Inc.	Biologically active taxane analogs and methods of treatment by oral administration
EP1946747A1 (fr) *	2007-01-17	2008-07-23	Sandoz AG	Composition pharmaceutique à stabilité améliorée contenant des dérivés de taxane
WO2008109360A1 (fr) *	2007-02-28	2008-09-12	Tapestry Pharmaceuticals, Inc	Analogues de taxane pour le traitement du cancer du cerveau
MX2010002179A (es) *	2007-08-24	2010-04-27	Stichting Het Nl Kanker I	Composicion para el tratamiento de enfermedades neoplasicas.
US9089544B2 (en) *	2007-08-24	2015-07-28	Slotervaart Participaties Bv	Composition
MX2010005198A (es) *	2007-11-12	2010-05-20	Novartis Ag	Composiciones liquidas que comprenden valsartan.
EP2077132A1 (fr)	2008-01-02	2009-07-08	Boehringer Ingelheim Pharma GmbH & Co. KG	Dispositif distributeur, dispositif de stockage et procédé pour la distribution d'une formulation
ES2344674B1 (es)	2008-08-07	2011-06-29	Gp Pharm, S.A.	Composicion farmaceutica inyectable de taxanos.
BRPI0920209A2 (pt)	2008-10-15	2015-12-22	Angiochem Inc	conjugados de agonistas de glp-1 e usos dos mesmos
US10011906B2 (en)	2009-03-31	2018-07-03	Beohringer Ingelheim International Gmbh	Method for coating a surface of a component
WO2010133294A2 (fr)	2009-05-18	2010-11-25	Boehringer Ingelheim International Gmbh	Adapteur, dispositif d'inhalation et nébuliseur
CN102038635A (zh)	2009-10-23	2011-05-04	天津天士力集团有限公司	一种含有pH值调节剂的紫杉烷类药物溶液及其制备方法
JP5658268B2 (ja)	2009-11-25	2015-01-21	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	ネブライザ
EA026241B1 (ru)	2009-11-25	2017-03-31	Бёрингер Ингельхайм Интернациональ Гмбх	Распылитель
US10016568B2 (en)	2009-11-25	2018-07-10	Boehringer Ingelheim International Gmbh	Nebulizer
WO2011160932A1 (fr)	2010-06-24	2011-12-29	Boehringer Ingelheim International Gmbh	Nébuliseur
WO2012130757A1 (fr)	2011-04-01	2012-10-04	Boehringer Ingelheim International Gmbh	Appareil médical pourvu d'un récipient
US9827384B2 (en)	2011-05-23	2017-11-28	Boehringer Ingelheim International Gmbh	Nebulizer
WO2013152894A1 (fr)	2012-04-13	2013-10-17	Boehringer Ingelheim International Gmbh	Pulvérisateur comprenant des moyens de détrompage
EP2777691A1 (fr) *	2013-03-14	2014-09-17	Pharmachemie B.V.	Taxoïde - purification des excipients liquides
EP3030298B1 (fr)	2013-08-09	2017-10-11	Boehringer Ingelheim International GmbH	Nébuliseur
PL2835146T3 (pl)	2013-08-09	2021-04-06	Boehringer Ingelheim International Gmbh	Nebulizator
AU2015257878B2 (en)	2014-05-07	2019-08-08	Boehringer Ingelheim International Gmbh	Container, nebulizer and use
EA035261B1 (ru)	2014-05-07	2020-05-21	Бёрингер Ингельхайм Интернациональ Гмбх	Небулайзер и контейнер
HUE055604T2 (hu)	2014-05-07	2021-12-28	Boehringer Ingelheim Int	Porlasztó
CN103980232A (zh) *	2014-06-05	2014-08-13	北京诺普德医药科技有限公司	10-乙酰基多西紫杉醇及其用途
DK3307326T3 (da)	2015-06-15	2020-10-19	Angiochem Inc	Fremgangsmåder til behandling af leptomeningeal karcinomatose
TWI838700B (zh) *	2015-09-30	2024-04-11	香港商慧源香港創新有限公司	口服紫杉烷組合物及方法
CN108066335B (zh) *	2016-11-11	2020-02-21	北京康辰药业股份有限公司	一种含有紫杉醇或其类似物的药物组合物及其制备方法
FR3113238B1 (fr)	2020-08-05	2024-04-05	Gattefosse Sas	Utilisation comme excipient, d’un melange de macrogolglyceride laurique et de polyethylene glycol

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2601675B1 (fr) *	1986-07-17	1988-09-23	Rhone Poulenc Sante	Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
US4960790A (en) *	1989-03-09	1990-10-02	University Of Kansas	Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
US5817321A (en) *	1992-10-08	1998-10-06	Supratek Pharma, Inc.	Biological agent compositions
ES2224200T3 (es) *	1992-11-27	2005-03-01	Mayne Pharma (Usa) Inc.	Composicion inyectable estable de paclitaxel.
US6245805B1 (en) *	1995-10-26	2001-06-12	Baker Norton Pharmaceuticals, Inc.	Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
US6964946B1 (en) *	1995-10-26	2005-11-15	Baker Norton Pharmaceuticals, Inc.	Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
US6395770B1 (en) *	1995-10-26	2002-05-28	Baker Norton Pharmaceuticals, Inc.	Method and compositions for administering taxanes orally to human patients
DE69735057T2 (de) *	1996-03-12	2006-08-31	PG-TXL Co., L.P., Houston	Wasserlösliche paclitaxel-prodrogen
US5756537A (en) *	1996-11-08	1998-05-26	Parkash S. Gill, M.D., Inc.	Regime for paclitaxel in Kaposi's sarcoma patients
US6515016B2 (en) *	1996-12-02	2003-02-04	Angiotech Pharmaceuticals, Inc.	Composition and methods of paclitaxel for treating psoriasis
US6495579B1 (en) *	1996-12-02	2002-12-17	Angiotech Pharmaceuticals, Inc.	Method for treating multiple sclerosis
US5980936A (en) *	1997-08-07	1999-11-09	Alliance Pharmaceutical Corp.	Multiple emulsions comprising a hydrophobic continuous phase
EP1067923A4 (fr) *	1997-12-31	2002-11-13	Bristol Myers Squibb Co	Analogues de 2-aroyl-4-acyl paclitaxel (taxel)
IL131217A0 (en) *	1998-03-10	2001-01-28	Napro Biotherapeutics Inc	Novel methods and compositions for delivery of taxanes
US6979456B1 (en) *	1998-04-01	2005-12-27	Jagotec Ag	Anticancer compositions
IL144976A0 (en) *	1999-05-17	2002-06-30	Bristol Myers Squibb Co	A process for the preparation of paclitaxel
CA2381401A1 (fr) *	1999-08-11	2001-02-15	Bristol-Myers Squibb Company	Procede de preparation d'un analogue de carbonate de methyle c-4 du paclitaxel
US6136846A (en) *	1999-10-25	2000-10-24	Supergen, Inc.	Formulation for paclitaxel
US6750246B1 (en) *	2000-02-03	2004-06-15	Bristol-Myers Squibb Company	C-4 carbonate taxanes
US6916942B2 (en) *	2000-02-03	2005-07-12	Bristol-Myers Squibb Company	Process for the preparation of C-4 carbonate taxanes
TWI310684B (en) *	2000-03-27	2009-06-11	Bristol Myers Squibb Co	Synergistic pharmaceutical kits for treating cancer
JP2004536026A (ja) *	2000-11-28	2004-12-02	トランスフォームファーマシューティカルズ，インコーポレーティッド．	パクリタキセル、その誘導体、および薬剤として許容される塩を含む医薬品製剤
TWI297335B (en) *	2001-07-10	2008-06-01	Synta Pharmaceuticals Corp	Taxol enhancer compounds
US20040092428A1 (en) *	2001-11-27	2004-05-13	Hongming Chen	Oral pharmaceuticals formulation comprising paclitaxel, derivatives and methods of administration thereof

2002
- 2002-12-12 CA CA002470826A patent/CA2470826A1/fr not_active Abandoned
- 2002-12-12 GE GE5614A patent/GEP20063806B/en unknown
- 2002-12-12 AU AU2002361701A patent/AU2002361701A1/en not_active Abandoned
- 2002-12-12 CN CNB028254708A patent/CN1273130C/zh not_active Expired - Fee Related
- 2002-12-12 WO PCT/US2002/040127 patent/WO2003053350A2/fr not_active Ceased
- 2002-12-12 IL IL16211802A patent/IL162118A0/xx unknown
- 2002-12-12 BR BRPI0215184-7A patent/BR0215184A/pt not_active IP Right Cessation
- 2002-12-12 HR HR20040545A patent/HRP20040545A2/xx not_active Application Discontinuation
- 2002-12-12 EP EP02797339A patent/EP1465618A2/fr not_active Withdrawn
- 2002-12-12 RS YU52904A patent/RS52904A/sr unknown
- 2002-12-12 JP JP2003554110A patent/JP2006501134A/ja not_active Withdrawn
- 2002-12-12 PL PL02374283A patent/PL374283A1/xx not_active Application Discontinuation
- 2002-12-12 RU RU2004119557/15A patent/RU2004119557A/ru not_active Application Discontinuation
- 2002-12-12 HU HU0500843A patent/HUP0500843A2/hu unknown
- 2002-12-12 KR KR10-2004-7009593A patent/KR20040066921A/ko not_active Withdrawn
- 2002-12-16 TW TW091136275A patent/TW200302086A/zh unknown
- 2002-12-19 AR ARP020105039A patent/AR037951A1/es unknown
- 2002-12-19 US US10/323,551 patent/US20030220391A1/en not_active Abandoned
- 2002-12-20 UY UY27598A patent/UY27598A1/es not_active Application Discontinuation
2003
- 2003-01-06 PE PE2003000013A patent/PE20030742A1/es not_active Application Discontinuation
2004
- 2004-06-09 ZA ZA200404584A patent/ZA200404584B/en unknown
- 2004-06-10 IS IS7306A patent/IS7306A/is unknown
- 2004-06-16 MX MXPA04005877A patent/MXPA04005877A/es unknown
- 2004-07-19 NO NO20043101A patent/NO20043101L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CA2470826A1 (fr)	2003-07-03
AU2002361701A1 (en)	2003-07-09
AR037951A1 (es)	2004-12-22
EP1465618A2 (fr)	2004-10-13
WO2003053350A3 (fr)	2004-01-15
CN1273130C (zh)	2006-09-06
BR0215184A (pt)	2006-06-06
JP2006501134A (ja)	2006-01-12
ZA200404584B (en)	2005-09-13
US20030220391A1 (en)	2003-11-27
RU2004119557A (ru)	2005-04-20
TW200302086A (en)	2003-08-01
WO2003053350A2 (fr)	2003-07-03
NO20043101L (no)	2004-07-19
PL374283A1 (en)	2005-10-03
KR20040066921A (ko)	2004-07-27
CN1606437A (zh)	2005-04-13
HRP20040545A2 (en)	2005-08-31
IS7306A (is)	2004-06-10
PE20030742A1 (es)	2003-09-02
GEP20063806B (en)	2006-04-25
HUP0500843A2 (hu)	2005-12-28
RS52904A (sr)	2006-12-15
UY27598A1 (es)	2003-07-31
MXPA04005877A (es)	2004-09-13

Publication	Publication Date	Title
IL162118A0 (en)	2005-11-20	Pharmaceutical compositions containing an orally active taxane derivative
EP1461044A4 (fr)	2007-06-13	Compositions pharmaceutiques comprenant des composes actifs de vitamine d
IL159725A0 (en)	2004-06-20	Pharmaceutical compositions containing benzimidazole derivatives
IL157741A0 (en)	2004-03-28	Pharmaceutical compositions containing an antihyperplastic active agent
EP1631239A4 (fr)	2008-03-05	Compositions pharmaceutiques contenant des composes actifs de vitamine d
GB0111597D0 (en)	2001-07-04	Pharmaceutical compositions
GB0319041D0 (en)	2003-09-17	Pharmaceutical Formulations
AU2002341205A1 (en)	2002-11-18	Pharmaceutical compositions comprising cyclosporin
IL158898A0 (en)	2004-05-12	PHARMACEUTICAL COMPOSITIONS CONTAINING APOMORPHINE, 6aR-(-)-N-PROPYL-NORAPOMORPHINE AND DERIVATIVES THEREOF
IL156988A0 (en)	2004-02-08	Pharmaceutical compositions containing epothilone derivatives
IL157128A0 (en)	2004-02-08	Pharmaceutical compositions containing epothilone derivatives
HUP0400850A3 (en)	2010-10-28	Oral pharmaceutical compositions
GB0121715D0 (en)	2001-10-31	Pharmaceutical formulations
GB2380129B (en)	2004-08-11	Pharmaceutical formulations
GB0120701D0 (en)	2001-10-17	Pharmaceutical formulations
GB0103638D0 (en)	2001-03-28	Pharmaceutical formulations
HUP0402586A3 (en)	2011-05-30	Pharmaceutical compositions based on azetidine derivatives
GB0105560D0 (en)	2001-04-25	Pharmaceutical formulations
GB0104752D0 (en)	2001-04-18	Pharmaceutical compositions
EP1480649A4 (fr)	2006-04-26	Compositions pharmaceutiques stables
IL157849A0 (en)	2004-03-28	Pharmaceutical compositions containing (+) cannabidiol and derivatives thereof and some such novel derivatives
IL159614A0 (en)	2004-06-01	Benzofuran derivatives and pharmaceutical compositions containing the same
HUP0302531A3 (en)	2007-06-28	Pharmaceutical compositions containing citalopram
IL157356A0 (en)	2004-02-19	Pharmaceutical compositions containing a taxane derivative at a low dosage
GB2382302B (en)	2006-08-02	Pharmaceutical compositions